These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 36641004

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
    Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN.
    Trials; 2023 Aug 17; 24(1):538. PubMed ID: 37587492
    [Abstract] [Full Text] [Related]

  • 24. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
    Mathias MD, McCavit TL.
    Pediatrics; 2015 Mar 17; 135(3):475-82. PubMed ID: 25667245
    [Abstract] [Full Text] [Related]

  • 25. Patient-Controlled Analgesia Plus Background Opioid Infusion for Postoperative Pain in Children: A Systematic Review and Meta-Analysis of Randomized Trials.
    Hayes J, Dowling JJ, Peliowski A, Crawford MW, Johnston B.
    Anesth Analg; 2016 Oct 17; 123(4):991-1003. PubMed ID: 27065359
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of Vaso-occlusive Crisis Management With Patient-Controlled Analgesia in Children With Sickle Cell Disease Requiring Hospitalization.
    Arbitre C, Pastore Y, Bailey B, Kleiber N, Robitaille N, Villeneuve E, Viau A, Bergeron MJ, Trottier ED.
    J Pediatr Pharmacol Ther; 2021 Oct 17; 26(6):615-623. PubMed ID: 34421412
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain.
    Morris CR, Brown LAS, Reynolds M, Dampier CD, Lane PA, Watt A, Kumari P, Harris F, Manoranjithan S, Mendis RD, Figueroa J, Shiva S.
    Blood; 2020 Sep 17; 136(12):1402-1406. PubMed ID: 32384147
    [Abstract] [Full Text] [Related]

  • 29. Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage.
    Onyebuchi CO, Chumpitazi CE, Placencia JL, Jackson AN, Jones JL, Torres L, Tubman VN.
    J Pain Symptom Manage; 2024 Mar 17; 67(3):e169-e175. PubMed ID: 38000561
    [Abstract] [Full Text] [Related]

  • 30. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease.
    Harris EM, Vilk E, Heeney MM, Solodiuk J, Greco C, Archer NM.
    Pediatr Blood Cancer; 2021 Jul 17; 68(7):e28989. PubMed ID: 33788404
    [Abstract] [Full Text] [Related]

  • 31. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
    Collins JJ, Geake J, Grier HE, Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB.
    J Pediatr; 1996 Nov 17; 129(5):722-8. PubMed ID: 8917240
    [Abstract] [Full Text] [Related]

  • 32. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M, López-Sangüos C, Vázquez P, Alvárez T, Marañón R, Huerta J, Cela E.
    Hemoglobin; 2016 Nov 17; 40(6):388-391. PubMed ID: 28361592
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
    Ibemere SO, Dubbs SB, Barnhart HX, Brown JL, Freiermuth CE, Kavanagh P, Paice JA, Strouse JJ, Wilkerson RG, Tanabe P, COMPARE-VOE study investigators.
    Contemp Clin Trials; 2021 Feb 17; 101():106252. PubMed ID: 33348066
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.